Efficacy of secnidazole in the treatment of trichomoniasis and vaginal dysbiosis

Author:

Bezhena V. F.1ORCID,Molchanov O. L.2ORCID,Lazareva N. B.3ORCID,Galiullina L. A.1ORCID,Poznyak A. L.4ORCID

Affiliation:

1. Pavlov First Saint Petersburg State Medical University

2. Pavlov First Saint Petersburg State Medical University; North-Western State Medical University named after I.I. Mechnikov

3. Sechenov First Moscow State Medical University (Sechenov University); International Association of Clinical Pharmacology and Pharmacy

4. North-Western State Medical University named after I.I. Mechnikov

Abstract

Introduction. Trichomoniasis is a vaginal infectious and inflammatory disease, which falls into the category of sexually transmissible nosological entities. It is the profile of vaginal microecosystem changes in trichomoniasis that determines the vector of transformation of the vaginal microbiome towards the formation of bacterial vaginosis (BV), namely, a hypercolonized community of anaerobic microorganisms with underlying suppression of the dominant presence of the resident acidophilic microflora.Aim. To evaluate the clinical and bacteriological efficacy of 5-nitroimidazole drugs secnidazole and metronidazole in the therapy of acute trichomoniasis and concomitant vaginal dysbacteriosis.Materials and methods. As a comparison object, we used the therapy regimens for acute trichomoniasis with the 5-nitroimidazole drugs secnidazole and metronidazole, involving 2 grams (g) once as a single dose. The study included 64 patients diagnosed with acute trichomoniasis. The average age of the patients was 34 ± 7 years (95% CI 32–37). The patients were divided into two groups: group 1 (n = 32) used Secnidazole, group 2 (n = 32) used Secnidazole 2 g once as a single dose. Metronidazole was used at a dose of 500 mg 2 times a day for 5 days. Patients were observed by a doctor during two visits, and a follow-up assessment of the treatment results was carried out by way of remote interrogation.Results. The use of the drug therapy ensured removal of Trichomonas from the vagina. Both groups showed relief of clinical symptoms from B1 to B2: discomfort, itching, burning, dyspareunia, hyperemia of the mucosa with underlying tendency towards normalization of laboratory findings of the vaginal microbiocenosis condition. At the same time, it should be noted that the therapy efficiency was higher in group 1 (secnidazole).Conclusion. Thus, the administration of secnidazole provided greater therapeutic efficacy as compared with the use of the similar therapeutic dose and frequency of metronidazole to treat Trichomonas and, in combination with rehabilitation therapy, determined a more pronounced tendency towards normalization of the composition of the vaginal microflora.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference33 articles.

1. Ailamazyan E.K. (ed.). Infectious and inflammatory diseases in obstetrics and gynecology. Moscow: GEOTAR-Media; 2016. 320 p. (In Russ.) Available at: https://www.rosmedlib.ru/book/ISBN9785970439456.html.

2. Radzinskii V.E., Fuks A.M. (eds.). Gynecology. Moscow: GEOTAR-Media; 2016. 1000 p. (In Russ.) Available at: https://www.rosmedlib.ru/book/ISBN9785970442494.html.

3. Skripkin Yu.K., Butov Yu.S., Ivanov O.L. (ed.). Dermatovenerology. National Guidelines. Moscow: GEOTAR-Media; 2014. 1024 p. (In Russ.) Available at: https://www.rosmedlib.ru/book/ISBN9785970427965.html.

4. Engbring J.A., Alderete J.F. Characterization of Trichomonas vaginalis AP33 adhesin and cell surface interactive domains. Microbiology (Reading). 1998;144(Pt. 11):3011–3018. https://doi.org/10.1099/00221287-144-11-3011.

5. Garber G.E., Lemchuk-Favel L.T., Bowie W.R. Isolation of a cell-detaching factor of Trichomonas vaginalis. J Clin Microbiol. 1989;27(7):1548–1553. https://doi.org/10.1128/jcm.27.7.1548-1553.1989.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3